Dose-related sleep disturbances induced by coffee and caffeine. 1976

I Karacan, and J I Thornby, and M Anch, and G H Booth, and R L Williams, and P J Salis

In a 13-night sleep laboratory study, each of 18 normal young adult males twice received 1 cup of warm water, 1-, 2-, and 4-cup equivalents of regular coffee, a 4-cup equivalent of decaffeinated coffee, and a 4-cup equivalent of caffeine. All beverages were administered 30 min before bedtime according to a balanced Latin-square design. Regular coffee produced dose-related changes in most standard electroencephalogram-electrooculogram (EEG-EOG) sleep parameters, and the 4-cup equivalents of regular coffee and caffeine produced equivalent effects. Decaffeinated coffee had no effect. Regular coffee and caffeine caused rapid eye movement (REM) sleep to shift to the early part of the night and stages 3 and 4 sleep to shift to the later part. Coffee also produced dose-related changes in several subjects estimates of sleep characteristics. These results suggest that coffee and caffeine may be used in normal subjects to induce symptoms mimicking those of insomnia. Such a tool should promote further understanding of insomnia.

UI MeSH Term Description Entries
D008297 Male Males
D002110 Caffeine A methylxanthine naturally occurring in some beverages and also used as a pharmacological agent. Caffeine's most notable pharmacological effect is as a central nervous system stimulant, increasing alertness and producing agitation. It also relaxes SMOOTH MUSCLE, stimulates CARDIAC MUSCLE, stimulates DIURESIS, and appears to be useful in the treatment of some types of headache. Several cellular actions of caffeine have been observed, but it is not entirely clear how each contributes to its pharmacological profile. Among the most important are inhibition of cyclic nucleotide PHOSPHODIESTERASES, antagonism of ADENOSINE RECEPTORS, and modulation of intracellular calcium handling. 1,3,7-Trimethylxanthine,Caffedrine,Coffeinum N,Coffeinum Purrum,Dexitac,Durvitan,No Doz,Percoffedrinol N,Percutaféine,Quick-Pep,Vivarin,Quick Pep,QuickPep
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003069 Coffee A beverage made from ground COFFEA beans (SEEDS) infused in hot water. It generally contains CAFFEINE and THEOPHYLLINE unless it is decaffeinated.
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004569 Electroencephalography Recording of electric currents developed in the brain by means of electrodes applied to the scalp, to the surface of the brain, or placed within the substance of the brain. EEG,Electroencephalogram,Electroencephalograms
D004585 Electrooculography Recording of the average amplitude of the resting potential arising between the cornea and the retina in light and dark adaptation as the eyes turn a standard distance to the right and the left. The increase in potential with light adaptation is used to evaluate the condition of the retinal pigment epithelium. EOG,Electrooculograms,Electrooculogram
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012890 Sleep A readily reversible suspension of sensorimotor interaction with the environment, usually associated with recumbency and immobility. Sleep Habits,Sleeping Habit,Sleeping Habits,Habit, Sleep,Habit, Sleeping,Habits, Sleep,Habits, Sleeping,Sleep Habit

Related Publications

I Karacan, and J I Thornby, and M Anch, and G H Booth, and R L Williams, and P J Salis
February 1977, Clinical pharmacology and therapeutics,
I Karacan, and J I Thornby, and M Anch, and G H Booth, and R L Williams, and P J Salis
June 1983, Clinical pharmacology and therapeutics,
I Karacan, and J I Thornby, and M Anch, and G H Booth, and R L Williams, and P J Salis
January 1978, Orvosi hetilap,
I Karacan, and J I Thornby, and M Anch, and G H Booth, and R L Williams, and P J Salis
September 2018, Biomolecules & therapeutics,
I Karacan, and J I Thornby, and M Anch, and G H Booth, and R L Williams, and P J Salis
April 2012, Pharmacology, biochemistry, and behavior,
I Karacan, and J I Thornby, and M Anch, and G H Booth, and R L Williams, and P J Salis
January 1972, Zeitschrift fur Ernahrungswissenschaft. Journal of nutritional sciences. Supplementa,
I Karacan, and J I Thornby, and M Anch, and G H Booth, and R L Williams, and P J Salis
August 1986, Psychological reports,
I Karacan, and J I Thornby, and M Anch, and G H Booth, and R L Williams, and P J Salis
March 1986, Journal of the experimental analysis of behavior,
I Karacan, and J I Thornby, and M Anch, and G H Booth, and R L Williams, and P J Salis
September 1981, Comprehensive therapy,
I Karacan, and J I Thornby, and M Anch, and G H Booth, and R L Williams, and P J Salis
March 1984, Journal of gerontology,
Copied contents to your clipboard!